PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Citronensäure-Monohydrat→

Citronensaure Monohydrat PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
5949-29-1
Molecular formula
C6H10O8
Molecular weight
210.14 g/mol
Drug class
Citric acid monohydratepharmaceutical acidifying and buffering excipient
Mechanism of action
Dissociates in aqueous systems to provide citrate and hydrogen ions, adjusting pH and buffering capacity. It is mainly used as a formulation excipient or chemical reagent rather than a therapeutic API.
Indications / reported uses
  • Used as a pH adjuster, acidifying agent, buffer component or excipient in pharmaceutical and food formulations; no general therapeutic API indication should be assigned

Sources: USP–NF — Citric acid monohydrate monograph · PubChem — Citric acid monohydrate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Citronensaure Monohydrat PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Citronensaure Monohydrat Permitted Daily Exposure (PDE) report (the Citronensaure Monohydrat PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Citronensaure Monohydrat Occupational Exposure Limit (OEL) report (the Citronensaure Monohydrat OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.